Understanding how limb development is initiated at the genetic level
Translational regulation of limb bud initiation
This study is looking at how certain genes help shape the early development of limbs, using a special technique to see how proteins are made from these genes, which could help us understand more about growth and healing in the body.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10686265 on NIH RePORTER |
What this research studies
This research investigates the genetic mechanisms that control the early stages of limb development, focusing on how certain genes are regulated during this process. By utilizing a novel microfluidic technique called Ribo-ITP, the study aims to analyze the efficiency of protein synthesis from mRNA in very small cell samples, which is crucial for understanding limb bud initiation. The approach combines advanced ribosome profiling with traditional gene expression methods to uncover how specific genes contribute to limb growth. This could provide insights into developmental biology and potential implications for regenerative medicine.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with congenital limb malformations or those interested in the genetic basis of limb development.
Not a fit: Patients with conditions unrelated to limb development or those who are not affected by genetic factors influencing limb growth may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding limb development and potential therapies for limb-related congenital disorders.
How similar studies have performed: While the specific microfluidic approach is novel, similar research has successfully utilized ribosome profiling to study gene regulation in other developmental contexts.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Vokes, Steven Alexander — University of Texas at Austin
- Study coordinator: Vokes, Steven Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.